Literature DB >> 18266549

Cannabis and motor function: fMRI changes following 28 days of discontinuation.

Srinivasan S Pillay1, Jadwiga Rogowska, Gen Kanayama, Staci Gruber, Norah Simpson, Harrison G Pope, Deborah A Yurgelun-Todd.   

Abstract

The authors hypothesized that supplementary motor cortex (SMA) and anterior cingulate cortex (ACC) activation in chronic cannabis users, studied 4 to 36 hours after their last episode of use, would disappear by Day 28 of abstinence during finger-tapping tests. Eleven cannabis users and 16 comparison subjects were scanned during right (RFT) and left (LFT) finger-tapping tasks on a GE 1.5 Tesla scanner retrofitted with a whole body echo planar coil. Image analyses were conducted in SPM99 using an ROI approach to define each Brodmann area (BA). Differences in cerebral activation were examined in the left and right primary motor cortex (BA4), SMA (BA6), and ACC (BA24 and BA32 separately). The authors found diminished activation for contralateral BA6 from Day 0 to Day 28. For LFT, the authors also found: ipsilaterally diminished BA6 activation on Day 7, but not Day 0 or Day 28; ipsilaterally diminished BA32 activation on Day 0, but not Day 7 or Day 28; contralaterally diminished BA 4 activation on Day 28, but not Day 0 or Day 7; and contralaterally diminished BA32 activation on Day 0 and Day 28, but not Day 7. For RFT, the authors found ipsilaterally diminished BA32 activation on Days 0 and 7 but not on Day 28; contralaterally diminished BA32 activation on Days 0, 7, and 28; and ipsilaterally diminished BA6 activation on Days 0, 7, and 28. These results suggest that residual diminished brain activation is still observed after discontinuing cannabis use in motor cortical circuits. 2008 APA

Entities:  

Mesh:

Year:  2008        PMID: 18266549     DOI: 10.1037/1064-1297.16.1.22

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  16 in total

1.  Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment.

Authors:  L Cinnamon Bidwell; Jarrod M Ellingson; Hollis C Karoly; Sophie L YorkWilliams; Leah N Hitchcock; Brian L Tracy; Jost Klawitter; Cristina Sempio; Angela D Bryan; Kent E Hutchison
Journal:  JAMA Psychiatry       Date:  2020-08-01       Impact factor: 21.596

Review 2.  Medical consequences of marijuana use: a review of current literature.

Authors:  Adam J Gordon; James W Conley; Joanne M Gordon
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

3.  Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia.

Authors:  Johannes Rentzsch; Ada Stadtmann; Christiane Montag; Hagen Kunte; Doris Plöckl; Rainer Hellweg; Jürgen Gallinat; Golo Kronenberg; Maria Christiane Jockers-Scherübl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-07-17       Impact factor: 5.270

Review 4.  Weighing the Evidence: A Systematic Review on Long-Term Neurocognitive Effects of Cannabis Use in Abstinent Adolescents and Adults.

Authors:  Florian Ganzer; Sonja Bröning; Stefanie Kraft; Peter-Michael Sack; Rainer Thomasius
Journal:  Neuropsychol Rev       Date:  2016-04-28       Impact factor: 7.444

5.  Examining the effects of former cannabis use on cerebellum-dependent eyeblink conditioning in humans.

Authors:  Adam B Steinmetz; Chad R Edwards; Jennifer M Vollmer; Molly A Erickson; Brian F O'Donnell; William P Hetrick; Patrick D Skosnik
Journal:  Psychopharmacology (Berl)       Date:  2011-12-02       Impact factor: 4.530

Review 6.  Cannabis and psychosis/schizophrenia: human studies.

Authors:  Deepak Cyril D'Souza; Richard Andrew Sewell; Mohini Ranganathan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-16       Impact factor: 5.270

7.  Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.

Authors:  Erin L Karschner; Eugene W Schwilke; Ross H Lowe; W David Darwin; Ronald I Herning; Jean Lud Cadet; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2009-10       Impact factor: 3.367

8.  Cortico-cerebellar abnormalities in adolescents with heavy marijuana use.

Authors:  Melissa P Lopez-Larson; Jadwiga Rogowska; Piotr Bogorodzki; Charles Elliott Bueler; Erin C McGlade; Deborah A Yurgelun-Todd
Journal:  Psychiatry Res       Date:  2012-07-24       Impact factor: 3.222

Review 9.  Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences.

Authors:  Natania A Crane; Randi Melissa Schuster; Paolo Fusar-Poli; Raul Gonzalez
Journal:  Neuropsychol Rev       Date:  2012-11-06       Impact factor: 7.444

10.  Neuroimaging meta-analysis of cannabis use studies reveals convergent functional alterations in brain regions supporting cognitive control and reward processing.

Authors:  Julio A Yanes; Michael C Riedel; Kimberly L Ray; Anna E Kirkland; Ryan T Bird; Emily R Boeving; Meredith A Reid; Raul Gonzalez; Jennifer L Robinson; Angela R Laird; Matthew T Sutherland
Journal:  J Psychopharmacol       Date:  2018-01-17       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.